The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 45,577 | 798,619 | SH | SOLE | 798,619 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 33,492 | 346,313 | SH | SOLE | 346,313 | 0 | 0 | ||
AC Immune SA | Shares | H00263105 | 2,199 | 171,813 | SH | SOLE | 171,813 | 0 | 0 | ||
Acadia Healthcare Company, Inc. | Common | 00404A109 | 8,888 | 272,400 | SH | SOLE | 272,400 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 7,404 | 245,885 | SH | SOLE | 245,885 | 0 | 0 | ||
Acceleron Pharma Inc. | Common | 00434H108 | 12,027 | 283,383 | SH | SOLE | 283,383 | 0 | 0 | ||
Achillion Pharmaceuticals, Inc. | Common | 00448Q201 | 1,774 | 616,000 | SH | SOLE | 616,000 | 0 | 0 | ||
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 6,248 | 935,368 | SH | SOLE | 935,368 | 0 | 0 | ||
Adverum Biotechnologies, Inc. | Common | 00773U108 | 2,604 | 743,974 | SH | SOLE | 743,974 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Note 2.00% 8/15/19 | 00767EAB8 | 10,335 | 13,000,000 | PRN | SOLE | 13,000,000 | 0 | 0 | ||
Aetna Inc. | Common | 00817Y108 | 8,580 | 47,566 | SH | SOLE | 47,566 | 0 | 0 | ||
Affimed N.V. | Common | N01045108 | 1,827 | 1,405,324 | SH | SOLE | 1,405,324 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 78,884 | 659,618 | SH | SOLE | 659,618 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 7,885 | 144,072 | SH | SOLE | 144,072 | 0 | 0 | ||
Allergan plc | Shares | G0177J108 | 34,054 | 208,180 | SH | SOLE | 208,180 | 0 | 0 | ||
Allergan plc | 5.50% Convertible Preferred Series A | G0177J116 | 2,931 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
Alliqua BioMedical, Inc. | Common | 019621309 | 302 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 14,606 | 114,966 | SH | SOLE | 114,966 | 0 | 0 | ||
Amarin Corporation plc | Sponsored ADR | 023111206 | 3,835 | 956,300 | SH | SOLE | 956,300 | 0 | 0 | ||
AmerisourceBergen Corporation | Common | 03073E105 | 15,362 | 167,307 | SH | SOLE | 167,307 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 149,932 | 862,174 | SH | SOLE | 862,174 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 8,705 | 604,920 | SH | SOLE | 604,920 | 0 | 0 | ||
Anthem, Inc. | Common | 036752103 | 10,107 | 44,918 | SH | SOLE | 44,918 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y407 | 1,115 | 811,227 | SH | SOLE | 811,227 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 4,220 | 639,370 | SH | SOLE | 639,370 | 0 | 0 | ||
argenx SE | Sponsored ADR | 04016X101 | 2,934 | 46,466 | SH | SOLE | 46,466 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 15,358 | 442,600 | SH | SOLE | 442,600 | 0 | 0 | ||
Auris Medical Holding AG | Common | H03579101 | 457 | 774,504 | SH | SOLE | 774,504 | 0 | 0 | ||
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 5,119 | 624,288 | SH | SOLE | 624,288 | 0 | 0 | ||
AveXis, Inc. | Common | 05366U100 | 7,785 | 70,347 | SH | SOLE | 70,347 | 0 | 0 | ||
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 2,557 | 26,170 | SH | SOLE | 26,170 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 505 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | Common | 09058V103 | 2,206 | 449,255 | SH | SOLE | 449,255 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 141,957 | 445,607 | SH | SOLE | 445,607 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 43,671 | 489,745 | SH | SOLE | 489,745 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 8,387 | 47,093 | SH | SOLE | 47,093 | 0 | 0 | ||
Boston Scientific Corporation | Common | 101137107 | 6,559 | 264,600 | SH | SOLE | 264,600 | 0 | 0 | ||
Bristol-Myers Squibb Company | Common | 110122108 | 21,394 | 349,121 | SH | SOLE | 349,121 | 0 | 0 | ||
Cardinal Health, Inc. | Common | 14149Y108 | 386 | 6,300 | SH | SOLE | 6,300 | 0 | 0 | ||
Cascadian Therapeutics, Inc. | Common | 14740B606 | 2,741 | 740,769 | SH | SOLE | 740,769 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 157,991 | 1,513,904 | SH | SOLE | 1,513,904 | 0 | 0 | ||
Celldex Therapeutics, Inc. | Common | 15117B103 | 300 | 105,800 | SH | SOLE | 105,800 | 0 | 0 | ||
Cellectis S.A. | Sponsored ADR | 15117K103 | 9,044 | 310,250 | SH | SOLE | 310,250 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 23,218 | 230,158 | SH | SOLE | 230,158 | 0 | 0 | ||
Charles River Laboratories International, Inc. | Common | 159864107 | 9,391 | 85,804 | SH | SOLE | 85,804 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 1,948 | 286,472 | SH | SOLE | 286,472 | 0 | 0 | ||
Cigna Corporation | Common | 125509109 | 20,309 | 100,002 | SH | SOLE | 100,002 | 0 | 0 | ||
Clovis Oncology, Inc. | Common | 189464100 | 5,127 | 75,400 | SH | SOLE | 75,400 | 0 | 0 | ||
Coherus BioSciences, Inc. | Common | 19249H103 | 792 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 869 | 203,935 | SH | SOLE | 203,935 | 0 | 0 | ||
CVS Health Corporation | Common | 126650100 | 26,573 | 366,521 | SH | SOLE | 366,521 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | Common | 23257D103 | 1,932 | 209,962 | SH | SOLE | 209,962 | 0 | 0 | ||
Cytokinetics, Inc. | Common | 23282W605 | 2,855 | 350,300 | SH | SOLE | 350,300 | 0 | 0 | ||
CytomX Therapeutics, Inc. | Common | 23284F105 | 5,595 | 265,045 | SH | SOLE | 265,045 | 0 | 0 | ||
Danaher Corporation | Common | 235851102 | 1,411 | 15,203 | SH | SOLE | 15,203 | 0 | 0 | ||
Dermira, Inc. | Common | 24983L104 | 7,467 | 268,500 | SH | SOLE | 268,500 | 0 | 0 | ||
DexCom, Inc. | Common | 252131107 | 3,096 | 53,950 | SH | SOLE | 53,950 | 0 | 0 | ||
Diplomat Pharmacy, Inc. | Common | 25456K101 | 12,855 | 640,492 | SH | SOLE | 640,492 | 0 | 0 | ||
Edwards Lifesciences Corporation | Common | 28176E108 | 7,337 | 65,100 | SH | SOLE | 65,100 | 0 | 0 | ||
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 3,334 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
Eli Lilly & Company | Common | 532457108 | 32,357 | 383,099 | SH | SOLE | 383,099 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 7,088 | 914,548 | SH | SOLE | 914,548 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 5,723 | 456,000 | SH | SOLE | 456,000 | 0 | 0 | ||
Evolent Health, Inc. | Class A | 30050B101 | 1,507 | 122,500 | SH | SOLE | 122,500 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 11,820 | 388,822 | SH | SOLE | 388,822 | 0 | 0 | ||
Express Scripts Holding Company | Common | 30219G108 | 6,307 | 84,500 | SH | SOLE | 84,500 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | Shares | M46135105 | 5,592 | 930,398 | SH | SOLE | 930,398 | 0 | 0 | ||
Galapagos NV | Sponsored ADR | 36315X101 | 4,988 | 53,200 | SH | SOLE | 53,200 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 180,553 | 2,520,281 | SH | SOLE | 2,520,281 | 0 | 0 | ||
Glaukos Corporation | Common | 377322102 | 1,413 | 55,079 | SH | SOLE | 55,079 | 0 | 0 | ||
GlaxoSmithKline plc | Shares | 37733W105 | 12,734 | 359,000 | SH | SOLE | 359,000 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | Common | 37890U108 | 5,113 | 129,948 | SH | SOLE | 129,948 | 0 | 0 | ||
Global Medical REIT Inc. | Common | 37954A204 | 602 | 73,400 | SH | SOLE | 73,400 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 3,300 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
HCA Healthcare, Inc. | Common | 40412C101 | 5,572 | 63,432 | SH | SOLE | 63,432 | 0 | 0 | ||
HCP, Inc. | Common | 40414L109 | 1,187 | 45,500 | SH | SOLE | 45,500 | 0 | 0 | ||
Healthcare Realty Trust Incorporated | Common | 421946104 | 2,184 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | ||
Healthcare Trust of America, Inc. | Class A | 42225P501 | 1,382 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
Henry Schein, Inc. | Common | 806407102 | 2,194 | 31,400 | SH | SOLE | 31,400 | 0 | 0 | ||
Horizon Pharma plc | Shares | G4617B105 | 2,378 | 162,900 | SH | SOLE | 162,900 | 0 | 0 | ||
Humana Inc. | Common | 444859102 | 34,372 | 138,556 | SH | SOLE | 138,556 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 20,697 | 132,352 | SH | SOLE | 132,352 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 62,442 | 285,791 | SH | SOLE | 285,791 | 0 | 0 | ||
Impax Laboratories, Inc. | Common | 45256B101 | 2,070 | 124,335 | SH | SOLE | 124,335 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 65,660 | 693,275 | SH | SOLE | 693,275 | 0 | 0 | ||
Innoviva, Inc. | Common | 45781M101 | 3,531 | 248,803 | SH | SOLE | 248,803 | 0 | 0 | ||
Intercept Pharmaceuticals, Inc. | Note 3.250% 7/1/23 | 45845PAA6 | 5,486 | 6,900,000 | PRN | SOLE | 6,900,000 | 0 | 0 | ||
Intuitive Surgical, Inc. | Common | 46120E602 | 1,405 | 3,850 | SH | SOLE | 3,850 | 0 | 0 | ||
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 6,485 | 128,930 | SH | SOLE | 128,930 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 13,252 | 98,421 | SH | SOLE | 98,421 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 102,852 | 736,132 | SH | SOLE | 736,132 | 0 | 0 | ||
Karyopharm Therapeutics Inc. | Common | 48576U106 | 0 | 20 | SH | SOLE | 20 | 0 | 0 | ||
Koninklijke Philips N.V. | NY Registry Shares | 500472303 | 2,646 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
Lexicon Pharmaceuticals, Inc. | Common | 528872302 | 2,754 | 278,700 | SH | SOLE | 278,700 | 0 | 0 | ||
LTC Properties, Inc. | Common | 502175102 | 9,131 | 209,673 | SH | SOLE | 209,673 | 0 | 0 | ||
Mallinckrodt plc | Shares | G5785G107 | 1,396 | 61,900 | SH | SOLE | 61,900 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 19,330 | 123,950 | SH | SOLE | 123,950 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 11,831 | 858,586 | SH | SOLE | 858,586 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 40,862 | 506,026 | SH | SOLE | 506,026 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 74,400 | 1,322,195 | SH | SOLE | 1,322,195 | 0 | 0 | ||
Merus B.V. | Common | N5749R100 | 9,276 | 479,150 | SH | SOLE | 479,150 | 0 | 0 | ||
Mylan N.V. | Shares | N59465109 | 67,828 | 1,603,112 | SH | SOLE | 1,603,112 | 0 | 0 | ||
Myovant Sciences Ltd. | Common | G637AM102 | 5,056 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
NanoString Technologies, Inc. | Common | 63009R109 | 555 | 74,250 | SH | SOLE | 74,250 | 0 | 0 | ||
Natera, Inc. | Common | 632307104 | 4,367 | 485,758 | SH | SOLE | 485,758 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 25,222 | 325,067 | SH | SOLE | 325,067 | 0 | 0 | ||
Nevro Corp. | Common | 64157F103 | 13,437 | 194,621 | SH | SOLE | 194,621 | 0 | 0 | ||
New Senior Investment Group Inc. | Common | 648691103 | 6,682 | 883,919 | SH | SOLE | 883,919 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 32,063 | 381,882 | SH | SOLE | 381,882 | 0 | 0 | ||
Novavax, Inc. | Common | 670002104 | 708 | 571,000 | SH | SOLE | 571,000 | 0 | 0 | ||
Novo Nordisk A/S | Sponsored ADR | 670100205 | 14,588 | 271,800 | SH | SOLE | 271,800 | 0 | 0 | ||
NuVasive, Inc. | Common | 670704105 | 6,869 | 117,437 | SH | SOLE | 117,437 | 0 | 0 | ||
Omega Healthcare Investors, Inc. | Common | 681936100 | 15,967 | 579,785 | SH | SOLE | 579,785 | 0 | 0 | ||
Ovid Therapeutics Inc. | Common | 690469101 | 5,289 | 535,824 | SH | SOLE | 535,824 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 3,251 | 37,300 | SH | SOLE | 37,300 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 35,318 | 975,087 | SH | SOLE | 975,087 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 4,773 | 265,336 | SH | SOLE | 265,336 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 14,816 | 1,962,380 | SH | SOLE | 1,962,380 | 0 | 0 | ||
PRA Health Sciences, Inc. | Common | 69354M108 | 5,912 | 64,920 | SH | SOLE | 64,920 | 0 | 0 | ||
Protagonist Therapeutics, Inc. | Common | 74366E102 | 1,723 | 82,822 | SH | SOLE | 82,822 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 4,784 | 48,392 | SH | SOLE | 48,392 | 0 | 0 | ||
Quorum Health Corporation | Shares | 74909E106 | 148 | 23,725 | SH | SOLE | 23,725 | 0 | 0 | ||
Quotient Limited | Common | G73268107 | 1,037 | 209,519 | SH | SOLE | 209,519 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | Common | 74933V108 | 3,028 | 356,237 | SH | SOLE | 356,237 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 64,107 | 170,516 | SH | SOLE | 170,516 | 0 | 0 | ||
Revance Therapeutics, Inc. | Common | 761330109 | 1,152 | 32,225 | SH | SOLE | 32,225 | 0 | 0 | ||
The RMR Group Inc. | Class A | 74967R106 | 441 | 7,441 | SH | SOLE | 7,441 | 0 | 0 | ||
Sabra Health Care REIT, Inc. | Common | 78573L106 | 13,601 | 724,606 | SH | SOLE | 724,606 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 11,170 | 67,815 | SH | SOLE | 67,815 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 7,736 | 179,900 | SH | SOLE | 179,900 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 18,606 | 334,400 | SH | SOLE | 334,400 | 0 | 0 | ||
Seattle Genetics, Inc. | Common | 812578102 | 11,968 | 223,700 | SH | SOLE | 223,700 | 0 | 0 | ||
Senior Housing Properties Trust | Shares | 81721M109 | 12,382 | 646,554 | SH | SOLE | 646,554 | 0 | 0 | ||
Shire plc | Sponsored ADR | 82481R106 | 31,294 | 201,739 | SH | SOLE | 201,739 | 0 | 0 | ||
Smith & Nephew plc | Sponsored ADR | 83175M205 | 1,407 | 40,183 | SH | SOLE | 40,183 | 0 | 0 | ||
Spark Therapeutics, Inc. | Common | 84652J103 | 1,990 | 38,706 | SH | SOLE | 38,706 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 19,220 | 226,460 | SH | SOLE | 226,460 | 0 | 0 | ||
Stryker Corporation | Common | 863667101 | 4,877 | 31,500 | SH | SOLE | 31,500 | 0 | 0 | ||
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 1,752 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 2,494 | 164,500 | SH | SOLE | 164,500 | 0 | 0 | ||
TESARO, Inc. | Common | 881569107 | 4,773 | 57,595 | SH | SOLE | 57,595 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 5,414 | 859,322 | SH | SOLE | 859,322 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 30,000 | 1,583,108 | SH | SOLE | 1,583,108 | 0 | 0 | ||
TherapeuticsMD, Inc. | Common | 88338N107 | 2,537 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 26,197 | 137,968 | SH | SOLE | 137,968 | 0 | 0 | ||
Trillium Therapeutics Inc. | Common | 89620X506 | 3,285 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Shares | 90400D108 | 6,890 | 148,558 | SH | SOLE | 148,558 | 0 | 0 | ||
uniQure N.V. | Common | N90064101 | 6,521 | 332,850 | SH | SOLE | 332,850 | 0 | 0 | ||
United Therapeutics Corporation | Common | 91307C102 | 2,400 | 16,220 | SH | SOLE | 16,220 | 0 | 0 | ||
UnitedHealth Group Inc. | Class B | 91324P102 | 67,436 | 305,886 | SH | SOLE | 305,886 | 0 | 0 | ||
Valeant Pharmaceuticals International, Inc. | Common | 91911K102 | 3,990 | 192,000 | SH | SOLE | 192,000 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 5,281 | 87,996 | SH | SOLE | 87,996 | 0 | 0 | ||
Verona Pharma plc | Sponsored ADR | 925050106 | 3,278 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 96,474 | 643,762 | SH | SOLE | 643,762 | 0 | 0 | ||
Welltower Inc. | 6.50% Preferred Perpetual | 95040Q203 | 11,974 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Welltower Inc. | Common | 95040Q104 | 1,365 | 21,400 | SH | SOLE | 21,400 | 0 | 0 | ||
Wright Medical Group N.V. | Ordinary Shares | N96617118 | 5,923 | 266,781 | SH | SOLE | 266,781 | 0 | 0 | ||
Xencor, Inc. | Common | 98401F105 | 438 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 989 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
Zafgen, Inc. | Common | 98885E103 | 61 | 13,307 | SH | SOLE | 13,307 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 9,690 | 80,300 | SH | SOLE | 80,300 | 0 | 0 |